Manitou Investment Management Ltd. Has $21.28 Million Holdings in Danaher Co. (NYSE:DHR)

Manitou Investment Management Ltd. increased its holdings in shares of Danaher Co. (NYSE:DHR) by 0.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 92,685 shares of the conglomerate’s stock after purchasing an additional 481 shares during the quarter. Danaher makes up about 4.2% of Manitou Investment Management Ltd.’s investment portfolio, making the stock its 11th biggest holding. Manitou Investment Management Ltd.’s holdings in Danaher were worth $21,276,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Hengehold Capital Management LLC boosted its position in Danaher by 30.3% during the fourth quarter. Hengehold Capital Management LLC now owns 2,340 shares of the conglomerate’s stock valued at $537,000 after purchasing an additional 544 shares during the last quarter. True North Advisors LLC raised its stake in shares of Danaher by 70.8% during the 4th quarter. True North Advisors LLC now owns 1,720 shares of the conglomerate’s stock worth $395,000 after purchasing an additional 713 shares in the last quarter. Janney Montgomery Scott LLC boosted its holdings in shares of Danaher by 1.7% in the 4th quarter. Janney Montgomery Scott LLC now owns 184,484 shares of the conglomerate’s stock valued at $42,349,000 after buying an additional 3,161 shares during the last quarter. Daymark Wealth Partners LLC grew its stake in shares of Danaher by 0.9% in the fourth quarter. Daymark Wealth Partners LLC now owns 17,521 shares of the conglomerate’s stock valued at $4,022,000 after buying an additional 155 shares in the last quarter. Finally, Albion Financial Group UT increased its holdings in Danaher by 360.7% during the fourth quarter. Albion Financial Group UT now owns 1,290 shares of the conglomerate’s stock worth $296,000 after buying an additional 1,010 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.6 %

Shares of DHR stock opened at $245.73 on Friday. The stock has a market cap of $177.49 billion, a P/E ratio of 46.90, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83. Danaher Co. has a 1 year low of $225.42 and a 1 year high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The stock has a 50 day simple moving average of $234.90 and a 200 day simple moving average of $253.47.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the prior year, the company posted $2.02 EPS. The company’s revenue was up 3.1% compared to the same quarter last year. On average, research analysts predict that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be given a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.44%. Danaher’s dividend payout ratio is 20.61%.

Analyst Ratings Changes

A number of brokerages have recently commented on DHR. Barclays decreased their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. UBS Group reduced their price target on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. Robert W. Baird dropped their price objective on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a research note on Thursday, October 31st. Finally, StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $285.55.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.